The significance of anticardiolipin antibodies in patients with lupus nephritis

Abstract

The objective of this study was to determine whether anticardiolipin antibodies (ACL) in SLE patients are associated with a specific pattern of lupus nephritis and/or with renal microvascular changes. Patients with SLE, followed prospectively between June 1991-May 1994 at The Wellesley Hospital Lupus Clinic, who underwent a renal biopsy were included. The ACL was measured by the ELISA according to international standardized method. Renal biopsy morphology was assessed using the WHO criteria for the classification of lupus nephritis. Renal vascular changes included glomerular hyaline thrombi, intimal fibro sis and intraluminal thrombi of renal arterioles. There were 23 SLE patients. The mean age at diagnosis of SLE was 28.2 years and the mean disease duration was 6.3 years. Of these 10 (43%) had high levels of ACL. No difference in the frequency of severe nephritis (Class III and IV) was identified amongst patients with and without ACL. Mesangial nephritis was more common in patients with ACL 40% vs 0, p = 0.02). Glomerular hyaline thrombi occurred in 3 (13%) patients. None of them had positive ACL. Renal vascular lesions included intimal proliferation in 4 (ACL + , 1) occluded lumens by thrombi in 2 (ACL + 1). Our data indicate that the development of glomerular and/or microvascular changes is not related to the presence of ACL.

Keywords

Anticardiolipin Lupus Nephritis

Get full access to this article

View all access options for this article.

References

Asherson RA , Kant KS : Antiphospholipid antibodies and the kidney. J Rheumatol 1993; 20: 1268-72.

Amigo MC , Garcia-Torres R. , Robles M. , Bochicchio T. , Reyes PA : Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-5.

Kincaid-Smith P. , Fairley KF , Kloss M. : Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy related renal failure. Quart J Med 1988; 68: 795-815.

Magil AB , McFadden D. , Rae A. : Lupus glomerulonephritis with thrombotic microangiopathy. Human Pathol 1986; 17: 192-4.

Frampton G. , Hicks J. , Cameron JS : Significance of antiphospholipid antibodies in patients with lupus nephritis . Kidney Intern 1991; 39: 1225-31.

D'Agati V. , Junis CH , Williams G. , Appel GB : Anti-cardiolipin antibody and renal disease: a report of three cases. J Am Soc Nephrol 1990; 1: 777-84.

Hughson MD , Nadasdy T. , McCarty GA , Choler C. , Min KW , Silva F. : Am J Kid Dis 1992; 20: 150-8.

Farrugia E. , Torres VE , Gastineau D. , Michet CJ , Holley KE : Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kid Dis 1992; 20: 463-71.

Tan EM , Cohen AS , Fries JF , Masi AT , McShane DJ , Rothfield NF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.

10.

Bombardier C. , Gladman D. , Urowitz MB , Caron D. , Chang CH Derivation of the SLEDAI. Arthritis Rheum 1992; 35: 630-40.

11.

Harris EV , Gharavi AE , Patel S. , Hughes Grv : Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April, 1986. Clin Exp Immunol 1987; 68: 215-22.

12.

Austin HA , Muenz LR , Joyce KM , Antonovich TT , Kullick ME , Klippel JH , Decker JL , Balow JE Prognostic factors in lupus nephritis: Contribution of renal histologic data . Am J Med 1983; 75: 382-91.

13.

Asherson RA , Khamushta MA , Ordi-Ros J. et al. The primary antiphospholipid syndrome: Major clinical and serological features. Medicine 1989; 68: 366-74.

14.

Bakimer R. , Fishman P. , Blank M. , Sredni B. , Djaldetti M. , Shoenfeld Y. : Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody. J Clin Invest 1992; 89: 1558-63.

15.

Piette JC , Cacoub P. , Wechsler B. : Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-66.

16.

Love PE , Santovo SA : Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-98.

17.

Abu Shakra M. , Urowitz M. , Gladman D. , Farewell V. : The significance of anticardiolipin antibodies in SLE. Clinical and laboratory correlations. Am J Med (In press).

18.

Clueck HI , Kant Ics , Weiss MA , Pollak VE , Miller MA , Coots M. : Thrombosis in systemic lupus erythematosus. Arch Int Med 1984; 145: 1389-95.